32 Biosciences

Diversified life science company focused on Gut Microbiome medicine

Print
Claim My Business
Form C
View on Republic
Security Type
Crowd SAFE
Min Investment
$300
Location
ILLINOIS, IL
Offering Date
June 24, 2024
Expected Close Date
October 22, 2024
Target Raise
$50.00K-$1.24M
No. Investors
68
Security Price
$1
Website
32biosciences.com
Number of Employees
4
Cash
$3,277
Revenue
$0
Short Term Debt
$116
Cost of Goods
$0
Long Term Debt
$0
Net Income
$3,111

Key Deal Facts

Innovative Science: 2 Platform Technologies from The University of Chicago
Experienced Leadership and Strong Team: Former J&J and Abbott Executives
Three Scientific Founders: Gut Microbiome World Experts
Differentiation and Competitive Advantage: Category Defining Technologies
Large Market Opportunities: $19.4B Total Available Market and Growing
Peak Year Sales Projection: $6.8B Platform Technologies Lead Indications
Strategy: Reduce Risk, Increase Reward, Create Investor Exit Optionality

Management Team / Advisory Board Bios

Peter Farmakis
CEO, Board Member

Brian Yoor
Board Member

Jaime Contreras
Board Member

Patrick Hennessey
EVP, Chief Business and Strategy Officer

Dr. John Alverdy
Scientific Founder

Dr. Eugene Chang
Scientific Founder

Joseph Pierre
Scientific Founder
Amount Raised : $150,350
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment